Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 5 (2008), Issue 1 (January)

1. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease.
   FASEB J, 22(1): 138-45. [Abstract] [Full-text]
2. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.
   Neurology, 70(1): 25-34. [Abstract] [Full-text]
3. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.
   J Neurosci, 28(1): 3-9. [Abstract] [Full-text]
4. Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.
   J Med Chem, 51(1): 148-58. [Abstract] [Full-text]
5. Losing one's memory in early Alzheimer's disease.
   Qual Health Res, 18(1): 31-42. [Abstract] [Full-text]
6. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine.
   Neurobiol Aging, 29(2): 168-84. [Abstract] [Full-text]
7. Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.
   Neurobiol Aging, 29(2): 185-93. [Abstract] [Full-text]
8. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease.
   Neurobiol Aging, 29(2): 194-202. [Abstract] [Full-text]
9. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
   Neurobiol Aging, 29(2): 241-52. [Abstract] [Full-text]
10. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Neurobiol Aging, 29(2): 210-21. [Abstract] [Full-text]
11. Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography.
    Neurobiol Aging, 29(2): 203-9. [Abstract] [Full-text]
12. The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue.
    J Endocrinol, 196(1): 123-30. [Abstract] [Full-text]
13. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
    Biochem Biophys Res Commun, 366(3): 631-6. [Abstract] [Full-text]
14. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
    Genes Brain Behav, 7: 57-66. [Abstract] [Full-text]
15. Neurotrophic factors in Alzheimer's disease: role of axonal transport.
    Genes Brain Behav, 7: 43-56. [Abstract] [Full-text]
16. Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models.
    Genes Brain Behav, 7: 1-5. [Abstract] [Full-text]
17. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Neurology, 70(3): 191-9. [Abstract] [Full-text]
18. Variable phenotype of Alzheimer's disease with spastic paraparesis.
    J Neurochem, 104(3): 573-83. [Abstract] [Full-text]
19. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 79(2): 176-9. [Abstract] [Full-text]
20. Prolonged activation EEG differentiates dementia with and without delirium in frail elderly patients.
    J Neurol Neurosurg Psychiatry, 79(2): 119-25. [Abstract] [Full-text]
21. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Neurology, 70(4): 299-303. [Abstract] [Full-text]
22. Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease.
    Acta Radiol, 49(1): 91-7. [Abstract] [Full-text]
23. Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry.
    Acta Radiol, 49(1): 84-90. [Abstract] [Full-text]
24. Codon 129 polymorphism of prion protein gene in sporadic Alzheimer's disease.
    Eur J Neurol, 15(2): 173-8. [Abstract] [Full-text]
25. Sodium lactate differently alters relative EEG power and functional connectivity in Alzheimer's disease patients' brain regions.
    Eur J Neurol, 15(2): 150-5. [Abstract] [Full-text]
26. Membrane fusogenic activity of the Alzheimer's peptide A beta(1-42) demonstrated by small-angle neutron scattering.
    J Mol Biol, 376(2): 393-404. [Abstract] [Full-text]
27. An update on huperzine A as a treatment for Alzheimer's disease.
    Expert Opin Investig Drugs, 17(2): 209-15. [Abstract] [Full-text]
28. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
    J Neurosci, 28(5): 1213-23. [Abstract] [Full-text]
29. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.
    J Neurochem, 104(4): 1065-80. [Abstract] [Full-text]
30. Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools.
    J Neurochem, 104(4): 859-74. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.